image
Eton Pharmaceuticals, Inc. ETON
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 10.02
-4.21 %
$ 259 M
Market Cap
-38.54
P/E
BALANCE SHEET
31.7 M ASSETS
26.81%
Growth Rates
1Year 26.81%
3Years 6.44%
5Years 2.30%
7Years 0.00%
10Years 0.00%
16.3 M LIABILITIES
36.07%
Growth Rates
1Year 36.07%
3Years 15.13%
5Years 51.70%
7Years 0.00%
10Years 0.00%
15.5 M EQUITY
18.34%
Growth Rates
1Year 18.34%
3Years -0.40%
5Years -10.06%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Eton Pharmaceuticals, Inc.
image
Current Assets 26.8 M
Cash & Short-Term Investments 21.4 M
Receivables 3.41 M
Other Current Assets 2.04 M
Non-Current Assets 4.9 M
Long-Term Investments 0
PP&E 150 K
Other Non-Current Assets 4.75 M
Current Liabilities 16.2 M
Accounts Payable 1.85 M
Short-Term Debt 5.38 M
Other Current Liabilities 9.01 M
Non-Current Liabilities 22 K
Long-Term Debt 22 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 21.4 16.3 14.4 21.3 12.1 26.7 13.2
Short Term Investments 0 0 0 0 0 0 0
Receivables 3.4 1.9 5.5 48 K 0.5 0 0
Inventory 0.9 0.6 0.6 1.2 0.4 0 0
Other Current Assets 1.1 1.3 6.4 4.2 3.2 0.8 0.1
Total Current Assets 26.8 20.0 23.6 24.7 15.0 27.5 13.3
PP&E 0.1 0.3 0.2 1.0 1.3 0.8 0.1
Intangible Assets 4.7 4.8 3.6 0.6 0.7 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0
Other Long Term Assets 12 K 12 K 21 K 40 K 61 K 52 K 32 K
Other Assets 0 0 0 0 0 0 0
Total Assets 31.7 25.0 27.5 26.3 17.1 28.3 13.4
LIABILITIES
Accounts Payable 1.8 1.8 1.8 2.3 0.6 1.4 0.5
Short Term Debt 5.4 1.0 1.4 0.3 0 0 0
Other Current Liabilities 9.0 3.7 1.4 1.2 1.4 0.6 0.3
Total Current Liabilities 16.2 6.5 4.6 3.8 2.0 2.0 0.8
Long Term Debt 22 K 5.5 5.3 6.9 4.6 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0.5
Total Liabilities 16.3 12.0 9.8 10.7 6.5 2.0 1.3
EQUITY
Common Stock 26 K 25 K 25 K 24 K 18 K 18 K 6 K
Retained Earnings (104.1) (103.1) (94.1) (92.2) (64.2) (45.9) (8.6)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 (19.0)
Total Equity 15.5 13.1 17.6 15.7 10.6 26.3 12.1
Total Liabilities and Equity 31.7 25.0 27.5 26.3 17.1 28.3 13.4
SHARES OUTSTANDING
Common Shares Outstanding 25.6 25.1 25.2 21.0 17.8 6.4 17.5